Notre Dame Provost to Step Down

Posted: Updated:
Thomas Burish Thomas Burish

The University of Notre Dame will soon begin a search to replace Thomas Burish as the Charles and Jill Fischer Provost, after Burish announced he will step down at the end of his current term on July 1, 2020. Burish has served as provost since 2005 and also serves as chief academic officer responsible for the operations of all academics.

Burish was tasked with strengthening academics and the university's research commitment, and since 2006, research has doubled from $79 million to more than $212 million in 2017. Graduate School investments also more than doubled, with now more than 15 graduate programs and a 25 percent application increase. 

“It has been a great joy and privilege to return to my alma mater as provost and to be a part of Notre Dame’s distinctive excellence as a Catholic research university,” Burish said. “I have been honored to work with and learn from Father John and the Trustees, and with faculty, staff, and administrative colleagues who have displayed ever-rising standards of service and excellence."

The Wisconsin-native graduated summa cum laude from Notre Dame in 1972 and later co-authored, or co-edited, four books, and has contributed to over 15 other books. 

An international search for a successor to Burish will begin in the next few months, after a search committee is formed. Faculty and students will make up some of the members, with President John Jenkins serving as chair. The Board of Trustees will elect the next provost after being presented with the committee's recommendations. 

  • Perspectives

    • Circling Back on WeWork

      Back in July when we first discussed WeWork, this fast-growing but money-losing venture was one of the most talked-about IPOs in years. At that time, we noted that it was too early to say what would happen, but “it should be very interesting to watch it all play out.” Turns out, that was a massive understatement!

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Photo courtesy of MutualBank

      MutualBank President Dies

      The President and Chief Operating Officer of Muncie-based MutalBank Pat Botts has died. In a statement on Facebook posted Sunday, the company said the passing was unexpected.

    • Artist rendering of proposed headquarters for Ruoff Home Mortgage in Fort Wayne.

      Ruoff to Build New HQ in Downtown Fort Wayne

      Fort Wayne-based Ruoff Home Mortgage has announced plans to build a $43 million corporate headquarters in downtown Fort Wayne. Plans call for a 110-thousand square foot, nine-story structure, at the corner of Ewing Street and Jefferson Boulevard. The building would include leasable office and retail space, as well as a parking garage. It would overlook Parkview Field, home of the Fort Wayne Tin Caps minor league baseball team. The company is currently located on...

    • Photo courtesy of Indiana Premium outlets

      Simon Announces New Name for Shopping Center

      Indianapolis-based Simon Property Group Inc. (NYSE: SPG) has announced Edinburgh Premium Outlets will become Indiana Premium Outlets. The company says extensive enhancements are currently underway to reflect the new name and are slated for completion by Holiday 2019. 

    • (image provided by Purdue University)

      'PlaneEnglish' Technology Lands U.S. Air Force Funding

      Technology intended to help young pilots learn how to better communicate with air traffic controllers has caught the attention of the United States Air Force and earned the two Purdue University graduates, who developed the software, a $50,000 federal grant. The creators of the simulator technology PlaneEnglish have been awarded a Small Business Innovation Research award. 

    • FDA Approves Lilly Migraine Drug

      The U.S. Food and Drug Administration has given another approval for a drug from Indianapolis-based Eli Lilly and Co. (NYSE: LLY). The approval of REYVOW is for the treatment of patients with acute migraines.